1OY Stock Chart & Stats
€8.45
€0.20(2.42%)
At close: 4:00 PM EDT
€8.45
€0.20(2.42%)
Day’s Range― - ―
52-Week Range€5.70 - €9.20
Previous CloseN/A
Volume0.00
Average Volume (3M)17.00
Market Cap
€808.14M
Enterprise Value€588.75M
Total Cash (Recent Filing)€31.70M
Total Debt (Recent Filing)€77.10M
Price to Earnings (P/E)―
Beta1.10
Next Earnings
Dec 08, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.23
Shares Outstanding87,124,916
10 Day Avg. Volume0
30 Day Avg. Volume17
Financial Highlights & Ratios
PEG Ratio0.38
Price to Book (P/B)1.44
Price to Sales (P/S)2.11
P/FCF Ratio12.71
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€7.14Price Target Upside-15.48% Downside
Rating ConsensusHold
Number of Analyst Covering4
EPS Forecast (FY)<0.01
Revenue Forecast (FY)€3.50M
Bulls Say, Bears Say
Bulls Say
Strong Balance Sheet And Low LeverageVictrex's very low debt-to-equity (0.11) and high equity ratio provide durable financial flexibility. This limits refinancing risk, supports long qualification cycles in industrial and medical markets, and enables capital deployment for capacity, R&D or dividend policy without stressing liquidity.
High Gross And Healthy EBITDA MarginsSustained gross margin near 45% and an EBITDA margin above 20% indicate strong pricing power from specialized PAEK/PEEK products. Higher structural margins give buffer against input cost swings and support reinvestment in technical support, qualification and product development.
Exposure To Durable, High-value End MarketsVictrex serves markets where long qualification cycles, performance requirements and regulatory standards create sticky, repeatable demand. Applications like medical implants, aerospace and lightweighting in automotive support structural revenue streams and premium pricing over time.
Bears Say
Weak Revenue TrendRecent negative revenue growth signals demand or mix headwinds in core polymer sales. Over months this can reduce operating leverage, slow margin recovery, and lengthen the ROI on new product qualifications, constraining sustainable top-line momentum.
Declining Free Cash Flow GenerationA sharp drop in free cash flow growth weakens the company's ability to self-fund capex, capacity expansion or higher R&D intensity needed for engineered grades. Persistently lower FCF also limits flexibility on dividends and strategic M&A or partnership funding.
Eroding Profitability And Return On EquityDeclining net margins and a reduced ROE point to pressure on pricing, mix or cost control. Over the medium term this lowers capital returns to shareholders and may signal competitive or operational headwinds that hinder reinvestment and long-term value creation.
Victrex News
1OY FAQ
What was Victrex PLC’s price range in the past 12 months?
Victrex PLC lowest stock price was €5.70 and its highest was €9.20 in the past 12 months.
What is Victrex PLC’s market cap?
Victrex PLC’s market cap is €808.14M.
When is Victrex PLC’s upcoming earnings report date?
Victrex PLC’s upcoming earnings report date is Dec 08, 2026 which is in 131 days.
How were Victrex PLC’s earnings last quarter?
Victrex PLC released its earnings results on May 11, 2026. The company reported €0.201 earnings per share for the quarter, beating the consensus estimate of N/A by €0.201.
Is Victrex PLC overvalued?
According to Wall Street analysts Victrex PLC’s price is currently Overvalued.
Does Victrex PLC pay dividends?
Victrex PLC does not currently pay dividends.
What is Victrex PLC’s EPS estimate?
Victrex PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Victrex PLC have?
Victrex PLC has 87,124,916 shares outstanding.
What happened to Victrex PLC’s price movement after its last earnings report?
Victrex PLC reported an EPS of €0.201 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -1.567%.
Which hedge fund is a major shareholder of Victrex PLC?
Currently, no hedge funds are holding shares in DE:1OY
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Victrex Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
€7.14 (-15.48% Downside)
€7.14 (-15.48% Downside)
Blogger Sentiment
Bullish
DE:1OY Sentiment 100%
Sector Average ―
Sector Average ―
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-22.81%
12-Months-Change
Fundamentals
Return on Equity
3.19%
Trailing 12-Months
Asset Growth
-13.25%
Trailing 12-Months
Company Description
Victrex PLC
Operating globally through its subsidiaries, Victrex plc is a specialized producer and distributor of polymer materials. The company organizes its business into two core divisions: Industrial and Medical. It concentrates on creating PEEK and PAEK polymer-based solutions, delivering both partially processed and fully manufactured components. Furthermore, Victrex offers tailored solutions for medical device producers, markets thermoplastic polymer components, and conducts trading operations. Its diverse clientele spans the automotive, aerospace, energy, industrial, manufacturing, engineering, electronics, and healthcare industries. Established in 1993, Victrex plc maintains its corporate headquarters in Thornton-Cleveleys, United Kingdom.
1OY Stock 12 Month Forecast
Average Price Target
€7.14
▼(-15.48% Downside)